Explanation
Adverseeffectsaremore√ºikely fco-administered with amantadine
Excess activationoftheNMDAN-methvt-d-aspartate)receptormayplayarole inthepathoqenesisof
Azheimersdisease.MemantineisanantaqonistattheNMDA receptor.Other treatment optionsfor
Alzheimersdisease includecholinesterase inhibitors (e.g.tacrine,donepezil).Other drugs withNMDA
receptor antagonist propertiesincludeketamineand amantadine, which increasetheriskof psychosiswhen
co-administered.
@1MINENDOCRINE
